211 related articles for article (PubMed ID: 23706017)
1. A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines.
García-González P; Morales R; Hoyos L; Maggi J; Campos J; Pesce B; Gárate D; Larrondo M; González R; Soto L; Ramos V; Tobar P; Molina MC; Pino-Lagos K; Catalán D; Aguillón JC
J Transl Med; 2013 May; 11():128. PubMed ID: 23706017
[TBL] [Abstract][Full Text] [Related]
2. Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.
García-González PA; Schinnerling K; Sepúlveda-Gutiérrez A; Maggi J; Hoyos L; Morales RA; Mehdi AM; Nel HJ; Soto L; Pesce B; Molina MC; Cuchacovich M; Larrondo ML; Neira Ó; Catalán DF; Hilkens CM; Thomas R; Verdugo RA; Aguillón JC
Front Immunol; 2016; 7():458. PubMed ID: 27826300
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Tolerogenic Features on Dexamethasone-Modulated MPLA-Activated Dendritic Cells by MYC.
García-González PA; Maggi J; Schinnerling K; Sepúlveda-Gutiérrez A; Soto L; Neira O; Mehdi AM; Nel HJ; Pesce B; Aravena O; Molina MC; Catalán D; Thomas R; Verdugo RA; Aguillón JC
Front Immunol; 2019; 10():1171. PubMed ID: 31191540
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
Harry RA; Anderson AE; Isaacs JD; Hilkens CM
Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic Properties on Naive and Memory CD4
Maggi J; Schinnerling K; Pesce B; Hilkens CM; Catalán D; Aguillón JC
Front Immunol; 2016; 7():359. PubMed ID: 27698654
[TBL] [Abstract][Full Text] [Related]
6. Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.
Obreque J; Vega F; Torres A; Cuitino L; Mackern-Oberti JP; Viviani P; Kalergis A; Llanos C
Immunology; 2017 Dec; 152(4):648-659. PubMed ID: 28763099
[TBL] [Abstract][Full Text] [Related]
7. Comparison of media and serum supplementation for generation of monophosphoryl lipid A/interferon-γ-matured type I dendritic cells for immunotherapy.
Kolanowski ST; Sritharan L; Lissenberg-Thunnissen SN; Van Schijndel GM; Van Ham SM; ten Brinke A
Cytotherapy; 2014 Jun; 16(6):826-34. PubMed ID: 24529557
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of clinical grade human tolerogenic dendritic cells.
Naranjo-Gómez M; Raïch-Regué D; Oñate C; Grau-López L; Ramo-Tello C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE
J Transl Med; 2011 Jun; 9():89. PubMed ID: 21658226
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional analyses of proinsulin peptide-specific regulatory T cells induced by tolerogenic dendritic cells.
Suwandi JS; Laban S; Vass K; Joosten A; van Unen V; Lelieveldt BPF; Höllt T; Zwaginga JJ; Nikolic T; Roep BO
J Autoimmun; 2020 Feb; 107():102361. PubMed ID: 31776056
[TBL] [Abstract][Full Text] [Related]
10. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
[TBL] [Abstract][Full Text] [Related]
11. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets.
Luft T; Jefford M; Luetjens P; Toy T; Hochrein H; Masterman KA; Maliszewski C; Shortman K; Cebon J; Maraskovsky E
Blood; 2002 Aug; 100(4):1362-72. PubMed ID: 12149219
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Monophosphoryl Lipid A on Maturation of DCs from Patients with Acute Myeloid Leukaemia.
El Husseiny NM; El Fattah Attya Elkak WA; El Ansary MS; El Aziz El Khateeb EM; Mattar MW; El Demerdash DM
Iran J Immunol; 2017 Mar; 14(1):1-12. PubMed ID: 28341814
[TBL] [Abstract][Full Text] [Related]
13. NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment.
Dáňová K; Klapetková A; Kayserová J; Šedivá A; Špíšek R; Jelínková LP
Oncotarget; 2015 Jun; 6(16):14123-38. PubMed ID: 26053099
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of monophosphoryl lipid A and cytokine cocktail as maturation stimuli of immunogenic and tolerogenic dendritic cells for immunotherapy.
Raïch-Regué D; Naranjo-Gómez M; Grau-López L; Ramo C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE
Vaccine; 2012 Jan; 30(2):378-87. PubMed ID: 22085546
[TBL] [Abstract][Full Text] [Related]
15. Dendritic Cells Generated in the Presence of Platelet Lysate Have a Reduced Type 1 Polarization Capacity.
Tešić N; Pekle Simonič I; Roškar K; Rožman P; Švajger U
Immunol Invest; 2020 Apr; 49(3):215-231. PubMed ID: 31170833
[TBL] [Abstract][Full Text] [Related]
16. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.
Anderson AE; Swan DJ; Sayers BL; Harry RA; Patterson AM; von Delwig A; Robinson JH; Isaacs JD; Hilkens CM
J Leukoc Biol; 2009 Feb; 85(2):243-50. PubMed ID: 18971286
[TBL] [Abstract][Full Text] [Related]
17. Induction of tolerogenic vs immunogenic dendritic cells (DCs) in the presence of GM-CSF is regulated by the strength of signaling from monophosphoryl lipid A (MPLA) in association with glutathione and fetal hemoglobin gamma-chain.
Khatri I; Alexander C; Brandenburg K; Fournier K; Mach JP; Rietschel ET; Ulmer AJ; Terzioglu E; Waelli T; Gorczynski RM
Immunol Lett; 2009 May; 124(1):44-9. PubMed ID: 19379773
[TBL] [Abstract][Full Text] [Related]
18. Monophosphoryl lipid A plus IFNgamma maturation of dendritic cells induces antigen-specific CD8+ cytotoxic T cells with high cytolytic potential.
ten Brinke A; van Schijndel G; Visser R; de Gruijl TD; Zwaginga JJ; van Ham SM
Cancer Immunol Immunother; 2010 Aug; 59(8):1185-95. PubMed ID: 20336295
[TBL] [Abstract][Full Text] [Related]
19. Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific CD4
Jansen MAA; Spiering R; Ludwig IS; van Eden W; Hilkens CMU; Broere F
Front Immunol; 2019; 10():2068. PubMed ID: 31555285
[TBL] [Abstract][Full Text] [Related]
20. Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking.
Chen X; Murakami T; Oppenheim JJ; Howard OM
Blood; 2005 Oct; 106(7):2409-16. PubMed ID: 15956285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
